Antileishmanial activity of the estrogen receptor modulator raloxifene.
BACKGROUND: The treatment of leishmaniasis relies mostly on parenteral drugs with potentially serious adverse effects. Additionally, parasite resistance in the treatment of leishmaniasis has been demonstrated for the majority of drugs available, making the search for more effective and less toxic dr...
Saved in:
Main Authors: | Juliana Q Reimão (Author), Danilo C Miguel (Author), Noemi N Taniwaki (Author), Cristiana T Trinconi (Author), Jenicer K U Yokoyama-Yasunaka (Author), Silvia R B Uliana (Author) |
---|---|
Format: | Book |
Published: |
Public Library of Science (PLoS),
2014-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Tamoxifen is effective in the treatment of Leishmania amazonensis infections in mice.
by: Danilo C Miguel, et al.
Published: (2008) -
The Role of Selective Estrogen Receptor Modulators on Breast Cancer: From Tamoxifen to Raloxifene
by: Wen-Ling Lee, et al.
Published: (2008) -
Selective Estrogen Receptor Modulator-Like Activities of Herba epimedii Extract and its Interactions With Tamoxifen and Raloxifene in Bone Cells and Tissues
by: Liping Zhou, et al.
Published: (2021) -
Generation of luciferase-expressing Leishmania infantum chagasi and assessment of miltefosine efficacy in infected hamsters through bioimaging.
by: Juliana Q Reimão, et al.
Published: (2015) -
A Luciferase-Expressing Leishmania braziliensis Line That Leads to Sustained Skin Lesions in BALB/c Mice and Allows Monitoring of Miltefosine Treatment Outcome.
by: Adriano C Coelho, et al.
Published: (2016)